U.S. News & World Report is back with its latest rankings. Did your facility make the cut? 

Among general cardiologists, compensation increased nearly 8% from 2023 to 2024. Interventional cardiology and electrophysiology saw even larger jumps.

Impella heart pumps may not provide as much value when treating high-risk patients as early data suggested.

Restore Medical's ContraBand system was designed to address symptoms in HFrEF patients who do not respond to other therapies. 

Edwards, an early investor when the company first launched in 2017, said the acquisition will ensure its TMVR platform reaches as many patients as possible. 

Counties with no cardiologists tend to be “rural and socioeconomically disadvantaged,” researchers noted. The group called for policy reform and new technologies to help address the issue. 

The new images were captured at the European Synchrotron Radiation Facility using hierarchical phase-contrast tomography. One specialist called them "Google Earth for the human heart." 

Serious changes could be coming to a cardiology practice near you.

The BiVACOR technology was designed to serve as a bridge to heart transplant in patients with end-stage heart failure. Based on rotary blood pump technology, it is made of titanium and approximately the size of an adult’s fist.

According to the new proposal, the 2025 conversion factor would be $32.36, down approximately 2.8% from 2024. SCAI, MGMA and other groups have already stepped forward with warnings that these cuts could do significant damage to patient care.